I reviewed nine individually verifiable analyst price targets, each tied to a specific firm and date. They range from a low of $2 to a high of $15, with an arithmetic mean of approximately $7.17, which rounds to a central target of $7. The spread is unusually wide, signaling that analysts disagree on whether ENVX can regain momentum. In my view, this dispersion matters more than the average itself.
The most cautious revisions arrived in November 2026. B. Riley Securities downgraded to Neutral and cut its target to $2 from $9, while Craig-Hallum moved to Hold with a $2 target, down from $7. Oppenheimer shifted to Perform from Outperform, and William Blair had already dropped its Outperform rating. Earlier cuts included Northland Securities lowering to $5 from $16 in October and Cantor Fitzgerald trimming to $10 from $25 in August. On the higher end, Canaccord Genuity, StoneX, and Cantor Fitzgerald sit at $10, with Loop Capital at $15. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
This is not a settled consensus but a set of views still evolving with the company’s strategy changes. The mean serves as a reference point rather than a firm prediction.
Trading near $1.60, a move to the $7 central target would imply roughly 340% upside. That scale of re-rating would need sustained improvement across multiple quarters, not just one strong report. Enovix’s third quarter of 2026 showed both progress and pressure: revenue rose about 38% year over year to $11.04 million, yet the adjusted loss widened slightly to $0.15 per share from $0.14. Management guided fourth-quarter revenue to $9 million–$10 million, a year-over-year decline, and set 2027 revenue guidance at $65 million–$85 million, below consensus estimates near $78 million. The company also plans to cut 220 jobs for roughly $8.5 million in annual savings and will end system-level field testing of its pre-AI-2 smartphone batteries after missing energy-density targets.
Several factors could help. Management is focusing on smart eyewear, reporting a backlog of about 50,000 battery packs and roughly 19,000 units shipped this year. The drone, defense, and industrial pipeline grew about 18% to roughly $216 million, including an initial order for 100,000 batteries. Executives noted rising demand from U.S. and allied customers for batteries made outside China, which aligns with Enovix’s largely China-free supply chain and its South Korea facility. The balance sheet provides additional support, with about $512.2 million in cash, investments, and restricted cash at quarter-end and a $37 million backlog entering 2027.
Significant hurdles remain. Enovix posted a net loss of roughly $42 million in the third quarter and continues to burn cash. Exiting smartphone testing removes a sizable potential market, and the fourth-quarter guide points to a sequential decline. The 2027 outlook came in below consensus, while restructuring and leadership shifts introduce execution risk during a critical manufacturing phase. A special warrant dividend and repurchase of 2030 notes also reflect balance-sheet adjustments that some investors may view cautiously.
The stock sits near the bottom of its 52-week range of roughly $1.53 to $16.46, having given up most of its earlier gains. The $1.53 area offers nearby support, but former trading zones between $9 and $16 now act as heavy overhead resistance. A sustained move toward $7 would require both accumulation and a fundamental catalyst beyond a technical rebound.
Analyst targets generally reflect a roughly 12-month horizon, though exact periods vary. I’m watching the smart-eyewear ramp closely, along with conversion of drone and defense orders into revenue, the pace of cash burn relative to the $512 million cash position, progress on the South Korea capacity expansion, and any further analyst revisions. Quarterly results and updates to 2027 guidance will provide the clearest signals on whether the pivot is gaining traction.
Tickeron's AI Daily Buy/Sell Signals apply artificial intelligence to track thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on market conditions, technical patterns, and AI analysis. For a volatile name like ENVX, these signals can help identify shifts more efficiently than manual checks alone. I find them a useful complement when reviewing positions in fast-moving sectors.
The $7 central target for Enovix reflects the mean of nine verified analyst estimates spanning $2 to $15 and sits roughly 340% above the recent price near $1.60. Reaching it would demand a substantial re-rating, backed in theory by smart-eyewear and defense demand plus a strong cash position, yet challenged by persistent losses, the smartphone exit, below-consensus 2027 guidance, and recent downgrades. The wide range of views highlights real uncertainty. Investors should treat the target as a reference and focus on revenue trends, backlog conversion, and cash burn in upcoming quarters.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
It is expected that a price bounce should occur soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +15.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where ENVX advanced for three days, in 219 of 268 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
ENVX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ENVX as a result. In 69 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
The Moving Average Convergence Divergence Histogram (MACD) for ENVX turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 36 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
ENVX moved below its 50-day moving average on November 04, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ENVX crossed bearishly below the 50-day moving average on November 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENVX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for ENVX entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.885) is normal, around the industry mean (2.765). P/E Ratio (-3.494) is within average values for comparable stocks, (13.467). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.910). Dividend Yield (0.000) settles around the average of (0.091) among similar stocks. P/S Ratio (17.452) is also within normal values, averaging (9.055).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. ENVX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENVX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ElectricalProducts